Glythera Ltd, a young spin-out biotechnology company from the University of Bath, was set up to create a new generation of biological therapeutics through advanced glycosylation technologies. The company has core expertise in protein/peptide functionalisation and glycosylation technologies, imparting improved pharmacokinetic properties to biological therapeutics.
Glythera successfully raised its first round of investment in 2008, with research operations being conducted in dedicated laboratories situated on the campus of the University of Bath.
|
As at 31 Dec 2012 |
IP Group holding |
|
32.2% |
|
Holding represents undiluted beneficial equity interest excluding debt